September 2012 Issue of MMM
Mobile Guide 2012
Mobile technology is rapidly evolving, but the past year saw few shifts in the mobile strategies of pharma—with a tablet-sized exception. James Chase reports
More than twice as many MDs have seen an iPad-carrying rep this year than in 2011. How pharma is dazzling docs with the iPad
Mobile continues to transform healthcare delivery. James Chase caught up with LifeScan's Joe Shields for a list of trends that will shape the future.
There's little doubt that mobile will continue its tear across healthcare. Can we keep up? And what's next? We ask five digital gurus
A showcase of select healthcare marketing and media companies that offer mobile capabilities
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.